Enzarium Enzalutamide Capsules 40 mg is a prescription oral oncology medicine identified as containing Enzalutamide 40 mg per capsule.

Enzalutamide is a targeted hormonal anticancer medicine classified as an androgen receptor inhibitor.

It blocks androgen receptor signaling involved in prostate cancer growth and survival.

Enzalutamide is used in selected treatment settings for castration-resistant and castration-sensitive prostate cancer, depending on disease stage and applicable approvals.

The stated 40 mg capsule strength does not establish the prescribed daily dose. The treating oncologist determines the appropriate regimen and any necessary dose adjustments.

The exact manufacturer, pack size, capsule composition, storage conditions and approved indications of Enzarium must be verified from its approved Indian product documentation.

Marketed by Essentials Emporium Enterprises, Enzarium is listed within the oncology pharmaceutical category for hospitals, cancer treatment centres and authorized pharmaceutical buyers.

Key Product Features